Engineered Antibodies



The latest tools and technologies continue to reveal a deeper insight into genomic and proteomic changes in disease, in more physiologically relevant models, hence many new protein targets and biomarkers have emerged in recent years. This has led to a pressing need for drug compounds to be developed for these novel entities and, as a result, therapeutic antibodies and antibody fragments...